Evidence map›Paper›PMID 39688667›Full record

ArticleVirchows Archiv : an international journal of pathology2025

GLI1::FOXO4-rearranged kidney tumors: a potentially distinct renal subtype within the spectrum of GLI1-altered tumors?

Tamás Pancsa, Natálie Klubíčková, Nooshin K Dashti, Isidro Machado, Antonio Llombart-Bosch, Konstantinos Linos, Elaheh Mosaieby, Tomáš Vaněček, Lenka Maňáková, Michal Michal and 1 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tamás PancsaBioptical Laboratory, Ltd., Plzen, Czech Republic. pancsa@biopticka.cz.ORCID http://orcid.org/0009-0005-1643-6233
Natálie KlubíčkováBioptical Laboratory, Ltd., Plzen, Czech Republic.
Nooshin K DashtiDartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.
Isidro MachadoPathology Department, Instituto Valenciano de Oncología and Patologika Laboratory, Hospital Quirón-Salud, Valencia, Spain.
Antonio Llombart-BoschPathology Department, Instituto Valenciano de Oncología and Patologika Laboratory, Hospital Quirón-Salud, Valencia, Spain.
Konstantinos LinosDepartment of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Elaheh MosaiebyBioptical Laboratory, Ltd., Plzen, Czech Republic.
Tomáš VaněčekBioptical Laboratory, Ltd., Plzen, Czech Republic.
Lenka MaňákováDepartment of Pathology, Laboratoře Agel, Ltd., Nový Jičín, Czech Republic.
Michal MichalBioptical Laboratory, Ltd., Plzen, Czech Republic.
Michael MichalBioptical Laboratory, Ltd., Plzen, Czech Republic.

Funding

Cooperatio Program Research area SURGMinisterstvo Školství, Mládeže a Tělovýchovy SVV 260652
6 · The paper itself

Abstract

Pathogenic alterations, namely, fusions and amplifications, of the GLI1 gene have been identified in various mesenchymal tumors, including pericytoma with t(7;12), plexiform fibromyxoma, gastroblastoma, and other malignant mesenchymal neoplasms arising in the soft tissues, as well as in various visceral organs. However, only three cases of GLI1-rearranged renal tumors have been reported to date, comprising two low-grade spindle cell tumors with GLI1::FOXO4 fusion along with one GLI1-rearranged case with an unknown fusion partner. In this study, we analyzed three cases with GLI1::FOXO4 fusion and overlapping morphology. One of the cases was reported previously, but an extended clinical and immunohistochemical information is provided. The studied cases occurred in 2 female and 1 male patients aged 35, 55, and 62 years (mean 51 years). All three tumors affected the renal parenchyma and grew as unencapsulated but well-circumscribed solid masses containing occasional entrapped and dilated renal tubules. The tumor cells were organized in cords, nests, or fascicles, had a round to spindled shape, and exhibited only mild nuclear atypia and minimal mitotic activity. They had a sparse eosinophilic to clear cytoplasm and were embedded in myxocollagenous stroma. Immunohistochemically, all cases expressed GLI1 (albeit with variable intensity) and harbored GLI1::FOXO4 fusion. All three patients were treated solely by complete surgical excision. Case 1 was alive with unknown disease status, case 2 was alive without evidence of disease, and case 3 died of unrelated causes. Our study doubles the number of reported cases with GLI1::FOXO4 fusion. The so far absolute predilection of this fusion for renal tumors, coupled with the absence of reports of other GLI1 fusions in tumors of the kidney, might indicate the potential existence of a distinct renal subtype with morphological features similar to other GLI1-altered tumors. All four reported cases had an uneventful follow-up which, together with their low-grade morphological features, suggests that these tumors might have a favorable prognosis.

Indexed as

Biomarkers, TumorCell Cycle ProteinsForkhead Transcription FactorsGene RearrangementKidney NeoplasmsZinc Finger Protein GLI1AdultFemaleHumansImmunohistochemistryMaleMiddle AgedBiomarkers, TumorCell Cycle ProteinsForkhead Transcription FactorsFOXO4 protein, humanGLI1 protein, humanZinc Finger Protein GLI1GLI1-altered tumorsGLI1::FOXO4 fusionKidneySoft tissue

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.